NGM Biopharmaceuticals NGM
€ 1.48
0.0%
Geschäftsbericht 2023
hinzugefügt 11.03.2024
NGM Biopharmaceuticals Gewinn / Verlust 2011-2024 | NGM
Gewinn / Verlust Jährlich NGM Biopharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
127 M | 375 M | 1.37 B | 2.07 B | 831 M | - | - | - | - | - | - | - | - |
Anteile |
82.5 M | 80 M | 77.1 M | 68.5 M | 50.3 M | - | - | - | - | - | - | - | - |
Kurshistorie |
1.54 | 4.69 | 17.7 | 30.3 | 18.5 | - | - | - | - | - | - | - | - |
Nettogewinn |
-142 M | -163 M | -120 M | -102 M | -42.8 M | -493 K | -14.2 M | -6.92 M | - | - | - | - | - |
Umsatz |
4.42 M | 55.3 M | 77.9 M | 87.4 M | 104 M | 109 M | 77.1 M | 85.6 M | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-151 M | -166 M | -121 M | -104 M | -49.3 M | -4.31 M | -17.4 M | - | - | - | - | - | - |
Zinsaufwendungen |
-234 K | -132 K | -60 K | -593 K | -147 K | 199 K | -152 K | - | - | - | - | - | - |
EBITDA |
-149 M | -162 M | -115 M | -97.3 M | -41.7 M | 2.91 M | -11 M | -4.83 M | - | - | - | - | - |
Betriebsaufwand |
156 M | 222 M | 199 M | 191 M | 153 M | - | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
37.8 M | 40.5 M | 36.9 M | 27.2 M | 23.6 M | 17.3 M | 14.8 M | 11.8 M | - | - | - | - | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich NGM Biopharmaceuticals
2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
82.7 M | 82.5 M | 82 M | 81.9 M | 80.6 M | 79.3 M | 78 M | 78 M | 77.4 M | 77.1 M | 76 M | 70.6 M | 68.8 M | 68.3 M | 67.4 M | 67 M | 65.9 M | 61 M | 6.81 M | 6.94 M | 6.53 M | 6.2 M | 6.13 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Nettogewinn |
-28.8 M | -38.3 M | -47.6 M | - | -47.3 M | -46.5 M | -32.4 M | - | -28.9 M | -36.7 M | -27.5 M | - | -29.8 M | -25.6 M | -19.1 M | -15.9 M | -10.9 M | -7.67 M | -8.27 M | 14.2 M | -7.52 M | -3.2 M | -3.94 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Einnahmen |
582 K | 1.42 M | 2.25 M | - | 7.91 M | 8.29 M | 20.9 M | - | 18.6 M | 16.8 M | 21.6 M | - | 23.5 M | 19.8 M | 24.4 M | 31.1 M | 21.6 M | 25.3 M | 25.6 M | 47.1 M | 20.8 M | 22.1 M | 18.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-31 M | -40.6 M | -50.2 M | - | -48.3 M | -47.1 M | -32.6 M | - | -29 M | -36.6 M | -27.8 M | - | -30 M | -25.5 M | -20.7 M | -17.3 M | -13 M | -9.71 M | -9.34 M | 13.1 M | -8.47 M | -4.19 M | -4.72 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zinsaufwendungen |
-15 K | -134 K | -37 K | - | 78 K | 5 K | -45 K | - | 35 K | -187 K | 187 K | - | -68 K | -471 K | 380 K | - | 96 K | -6 K | -36 K | - | -14 K | 95 K | 22 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-30.5 M | -40 M | -49.6 M | - | -47.7 M | -45.7 M | -31.2 M | - | -27.5 M | -35 M | -26.3 M | - | -28.4 M | -23.8 M | -18.9 M | -17.3 M | -11.1 M | -7.81 M | -7.38 M | 13.1 M | -6.57 M | -2.49 M | -2.97 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsaufwand |
31.6 M | 42 M | 52.4 M | - | 56.2 M | 55.4 M | 53.5 M | - | 47.6 M | 53.4 M | 49.4 M | - | 53.4 M | 45.3 M | 45 M | - | 34.6 M | 35 M | 34.9 M | - | 29.3 M | 26.3 M | 23.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
8.67 M | 9.65 M | 11.6 M | - | 10.1 M | 9.93 M | 10.7 M | - | 8.87 M | 9.82 M | 8.72 M | - | 6.46 M | 6.79 M | 6.6 M | - | 5.61 M | 6.23 M | 5.37 M | - | 4.81 M | 3.46 M | 3.87 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung